Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Mattlws
    Junior Member
    • May 2016
    • 1

    #1

    Help with sgRNA CRISPR screen mapping to reference genome

    Hello everyone,

    I am relatively new to NGS and bioinformatics and am working on CRISPR screens in cell lines.

    I would like to create a reference genome containing approx 120 000 different sequences. I have a fasta and txt file containing all sgRNA sequences along with the gene they target, like this:

    "Gene" "id" "Sequence"
    "A1BG" "HGLibA_00001" "GTCGCTGAGCTCCGATTCGA"
    "A1BG" "HGLibA_00002" "ACCTGTAGTTGCCGGCGTGC"
    "A1BG" "HGLibA_00003" "CGTCAGCGTCACATTGGCCA"
    "A1CF" "HGLibA_00004" "CGCGCACTGGTCCAGCGCAC"
    "A1CF" "HGLibA_00005" "CCAAGCTATATCCTGTGCGC"
    "A1CF" "HGLibA_00006" "AAGTTGCTTGATTGCATTCT"
    "A2M" "HGLibA_00007" "CGCTTCTTAAATTCTTGGGT"
    ...

    I would like to create a reference genome so that I can map my reads to this file, allowing for one mismatch (BAM alignment?) .

    Thanks a lot,

    Matt
  • Dario1984
    Senior Member
    • Jun 2011
    • 166

    #2
    You can use bowtie2-build to build an index for mapping with bowtie2.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    22 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    19 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...